7/31/2025GE HealthCare Q2 Results Highlight Mixed Signals in China Amid Tariff ...

7/30/2025AstraZeneca's Lynparza Gains Approval for New Indication in China

7/30/2025J&J's Lazcluze Approved for NSCLC in China

7/30/2025Madrigal Secures Global Rights to CSPC's Oral GLP-1 Candidate in Majo...

7/30/2025Dr. Falk Pharma and Allianthera Partner to Advance Novel AhR Agonist f...

7/30/2025Zhongmou Thera Secures Major Funding to Advance Gene Therapy Pipleline

7/29/2025Merck Faces China Headwinds as Gardasil Pause Drags on Q2 Results

7/29/2025ImageneBio Debuts on Nasdaq After Inmagene and Ikena Merger with $75M ...

7/29/2025LTZ Therapeutics Teams Up with Eli Lilly to Propel Autoimmune Drug Inn...

7/29/2025Tigermed Completes Acquisition of Japanese CRO Micron

7/29/2025AstraZeneca Reports Steady China Business Growth in 2025 H1 Amidst Glo...

7/29/2025Hengrui Boosts R&D Ambitions with Strategic Stake Purchase in Shengdi ...

7/28/2025AriBio Secures $1 Billion Deal with Fosun's Puxing Pharma for Alzheime...

7/28/2025Ab&B Biotech Clear Important Step to Hong Kong Listing

7/28/2025Everest Secures $200M in Share Placement While Epirium Bio Pursues $55...

7/28/2025GSK Secures Up to $12.5 B Deal with Hengrui to Power Its Next Wave of...

7/28/2025VelaVigo Announces Over $60M in Pre-A+ Financing

7/26/2025China's Sciwind in Licensing Talks to Bring Weight-Loss Drug to U.S. M...

7/25/2025Newish Secures Series B1 Investment to Propel Nucleic Acid Cancer Vac...

7/25/2025Everest Secures $200M in Share Placement while Epirium Bio Prepares $5...

7/24/2025Roche Sees Strong China Pharma Growth in H12025

7/24/2025Pfizer Finalizes 3SBio Deal, Prepares Global Phase 3 Launch for BsAb S...

7/24/2025Zonsen PepLib Biotech Closes ~CNY 100M Series B Round

7/22/2025Novatim Licenses Global Rights for Dual-Target CAR-T Therapy KQ-2003 t...

7/22/2025Leads Biolabs' Hong Kong IPO Draws HK$220B in Overwhelming Demand

7/22/2025Suzhou Ribo Raises Over CNY 200M to Advance siRNA Therapeutics

7/22/2025Lannacheng Secures Over CNY 300M in Series C+ to Advance Radiopharma P...

7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines

7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care

7/18/2025Novartis CEO Highlights China Momentum in Q2 2025 Earnings Call

Page:16/25 Total number of articles:746: [First][<<] [14] [15] [16] [17] [18] [>>] [End]